Last reviewed · How we verify
ALDHbr Umbilical Cord Blood Cells
ALDHbr Umbilical Cord Blood Cells is a Biologic drug developed by Joanne Kurtzberg, MD. It is currently in Phase 1 development.
At a glance
| Generic name | ALDHbr Umbilical Cord Blood Cells |
|---|---|
| Sponsor | Joanne Kurtzberg, MD |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ALDHbr Umbilical Cord Blood Cells CI brief — competitive landscape report
- ALDHbr Umbilical Cord Blood Cells updates RSS · CI watch RSS
- Joanne Kurtzberg, MD portfolio CI
Frequently asked questions about ALDHbr Umbilical Cord Blood Cells
What is ALDHbr Umbilical Cord Blood Cells?
ALDHbr Umbilical Cord Blood Cells is a Biologic drug developed by Joanne Kurtzberg, MD.
Who makes ALDHbr Umbilical Cord Blood Cells?
ALDHbr Umbilical Cord Blood Cells is developed by Joanne Kurtzberg, MD (see full Joanne Kurtzberg, MD pipeline at /company/joanne-kurtzberg-md).
What development phase is ALDHbr Umbilical Cord Blood Cells in?
ALDHbr Umbilical Cord Blood Cells is in Phase 1.